WAVE Life Sciences (WVE) Misses Q2 EPS by 4c

WAVE Life Sciences (NASDAQ: WVE) reported Q2 EPS of ($0.34), $0.04 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $2.3 million versus the consensus estimate of $7.65 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Paramount Weighs Tapping Musk For Equity Investment - Semafor
• US Treasury To Buy Back Up To $6B In Longer-dated Debt Thu. - Bloomberg
• DelphX closes C$61,000 non-brokered private placement